Terns Pharmaceuticals
Foster City, US · Founded 2020 · Delaware corporation · 4 known investors
Terns Pharmaceuticals is a biopharmaceutical company developing therapies, including its TERN-701 program. As of May 5, 2026, it operates as a subsidiary of Merck & Co., Inc. (known as MSD outside the US and Canada).
Founders & leadership
MV
Mark Vignola, Ph.D.Executive
BY
Bryan YoonExecutive
SS
Senthil SundaramExecutive
WZ
Weidong Zhong, Ph.D.Named on SEC filing
JQ
Jill QuigleyNamed on SEC filing
DF
David FellowsNamed on SEC filing
EW
Elise WangNamed on SEC filing
Board
YS
Yi Shi, Ph.D.Board director
HL
Hongbo Lu, Ph.D.Board director
CG
Carl Gordon, Ph.D.Board director
JK
Jeffrey KindlerBoard director
Investors · 4
Funding
SEC filings, press & company announcements$97.7M disclosed across 1 of 3 rounds · 2020–2025
- Undisclosed amountpublic offeringDec 2025Source ↗
- Undisclosed amountfollow-on equity offeringDec 2025Source ↗
▶$97.7MraisedJan 2021 · 13 investors · PharmaceuticalsRule 506(b)
▶$97.7MraisedJan 2021 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Weidong Zhong, Ph.D.Executive Officer, Director
- Jill QuigleyDirector
- David FellowsDirector
- Jeffrey KindlerDirector
- Mark Vignola, Ph.D.Executive Officer
- Bryan YoonExecutive Officer
- Yi Shi, Ph.D.Director
- Hongbo Lu, Ph.D.Director
- Carl Gordon, Ph.D.Director
- Elise WangDirector
- Senthil SundaramDirector, Executive Officer
- Offering amount
- $97.7M
- Amount sold
- $97.7M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Seeking Alpha29 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Robinhood24 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies competing with Terns Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Merck Stock Jumps on Phase 3 Cancer Vaccine Win as Keytruda Risk Easestradingkey.com · Aug 2026
Can Merck & Company (MRK)’s Stake in Evaxion A/S (EVAX) Validate the Potential of AI-Driven Vaccine Discovery? - Insider Monkeyinsidermonkey.com · Aug 2026Frequently asked questions
- What does Terns Pharmaceuticals do?
- Terns Pharmaceuticals is a biopharmaceutical company developing therapies, including its TERN-701 program. As of May 5, 2026, it operates as a subsidiary of Merck & Co., Inc. (known as MSD outside the US and Canada).
- Who are Terns Pharmaceuticals's investors?
- Terns Pharmaceuticals's investors include Decheng Capital, LAV, Lilly Asia Ventures, Vivo Capital.
- How much funding has Terns Pharmaceuticals raised?
- Terns Pharmaceuticals has disclosed $97.7M raised across 1 of its 3 known rounds.
- Where is Terns Pharmaceuticals headquartered?
- Terns Pharmaceuticals is headquartered in Foster City, US.